Concepedia

Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates

Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek A. Cogan, Xin Guo, Neil Moss, Jean Hugues Parmentier, J. R. Richman, Nicholas F. Brown

Journal of Pharmacology and Experimental Therapeutics · 2016 · 26 citations · 20 references

DOI

Concepts

References

20

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

, , +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

, , +16

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine · 1993 · 5.4K citations

, , +13

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan et al. · JAMA · 2015 · 688 citations · Full text

, , +17

Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.

The American Journal of Cardiology · 1996 · 490 citations

, , +12